| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BCMD.2005.04.005 |
| P698 | PubMed publication ID | 15935710 |
| P2093 | author name string | Funmei Yang | |
| David J Haile | |||
| Xiao-Bing Liu | |||
| P433 | issue | 1 | |
| P304 | page(s) | 33-46 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Blood Cells, Molecules and Diseases | Q15758051 |
| P1476 | title | Functional consequences of ferroportin 1 mutations | |
| P478 | volume | 35 |
| Q45905043 | A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro. |
| Q54290351 | A structural model of human ferroportin and of its iron binding site. |
| Q38410026 | Analysis of Ferrous on Ten-Eleven Translocation Activity and Epigenetic Modifications of Early Mouse Embryos by Fluorescence Microscopy |
| Q33728846 | Ceruloplasmin-ferroportin system of iron traffic in vertebrates |
| Q84950080 | Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation |
| Q37021503 | Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations |
| Q47615199 | Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer. |
| Q35642812 | Evidence for the multimeric structure of ferroportin |
| Q42026727 | Ferroportin and Erythroid Cells: An Update |
| Q91685806 | Ferroportin disease mutations influence manganese accumulation and cytotoxicity |
| Q47109362 | Ferroportin disease: pathogenesis, diagnosis and treatment. |
| Q47783604 | Ferroportin diseases: functional studies, a link between genetic and clinical phenotype |
| Q37032107 | Ferroportin-mediated iron transport: expression and regulation |
| Q39784883 | Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. |
| Q33702877 | Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc |
| Q39629166 | G80S-linked ferroportin disease: Classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective |
| Q44457164 | Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types |
| Q37929067 | Hepcidin and ferroportin: the new players in iron metabolism |
| Q27690828 | Hepcidin and iron regulation, 10 years later |
| Q33563777 | Hepcidin antagonists for potential treatments of disorders with hepcidin excess |
| Q24337699 | Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination |
| Q37129387 | Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. |
| Q33628733 | Human macrophage ferroportin biology and the basis for the ferroportin disease |
| Q33788725 | Human mutation D157G in ferroportin leads to hepcidin-independent binding of Jak2 and ferroportin down-regulation |
| Q47170728 | Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction |
| Q28294061 | Impaired iron transport activity of ferroportin 1 in hereditary iron overload |
| Q46985588 | In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation |
| Q30487384 | Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter |
| Q41211121 | Iron addiction: a novel therapeutic target in ovarian cancer |
| Q37325173 | Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium |
| Q37087636 | Iron homeostasis and erythropoiesis |
| Q34651435 | Iron imports. III. Transfer of iron from the mucosa into circulation |
| Q36376662 | Iron overload due to mutations in ferroportin. |
| Q38098239 | Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations. |
| Q35032747 | Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy |
| Q28087429 | Ironing out Ferroportin |
| Q58605164 | Liver iron sensing and body iron homeostasis |
| Q36177913 | Liver iron transport |
| Q36675326 | Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations |
| Q35578602 | Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload |
| Q43082361 | Molecular and clinical correlates in iron overload associated with mutations in ferroportin. |
| Q42629549 | Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages |
| Q64114549 | New Insights into the Hepcidin-Ferroportin Axis and Iron Homeostasis in iPSC-Derived Cardiomyocytes from Friedreich's Ataxia Patient |
| Q38547572 | New perspectives on the regulation of iron absorption via cellular zinc concentrations in humans. |
| Q34304892 | Non-HFE hemochromatosis |
| Q27321351 | Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin |
| Q37139716 | RETRACTED: The hepcidin-binding site on ferroportin is evolutionarily conserved |
| Q36862359 | Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin |
| Q36995110 | Regulation of iron acquisition and storage: consequences for iron-linked disorders |
| Q34476015 | Role of hepcidin in murine brain iron metabolism |
| Q46152147 | Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin |
| Q39137463 | Structure-function analysis of the human ferroportin iron exporter (SLC40A1): effect of hemochromatosis type 4 disease mutations and identification of critical residues. |
| Q48168878 | The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation. |
| Q24678328 | The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease |
| Q40290550 | The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica |
| Q36838527 | The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. |
| Q37271055 | The molecular basis of hepcidin-resistant hereditary hemochromatosis |
| Q37826382 | The molecular basis of iron overload disorders and iron-linked anemias |
| Q38316682 | The molecular circuitry regulating the switch between iron deficiency and overload in mice |
| Q35901835 | The molecular mechanism of hepcidin-mediated ferroportin down-regulation |
| Q90041254 | Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features |
| Q42026895 | Wild-type and mutant ferroportins do not form oligomers in transfected cells. |
| Q36141710 | Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations |
Search more.